Regulation

How Is Egypt Becoming a Regional Health Investment Hub?
Business How Is Egypt Becoming a Regional Health Investment Hub?

Egypt stands at a pivotal moment in its healthcare evolution, with investments soaring to unprecedented levels and a vision to transform into a regional health powerhouse that attracts attention across the Middle East and Africa. Recent data reveals that the nation is spearheading 1,300 health

Can Phage Therapy Defeat Superbugs in France's Breakthrough?
Public Policy Can Phage Therapy Defeat Superbugs in France's Breakthrough?

Understanding the Crisis of Antimicrobial Resistance and the Need for Alternatives The global health landscape is under siege as antimicrobial resistance (AMR) escalates into a formidable threat, claiming an estimated 3,500 lives daily worldwide, according to data from the World Health

GSK Expands COPD Pipeline with $85M Drug Acquisition
Care GSK Expands COPD Pipeline with $85M Drug Acquisition

In a landscape where chronic respiratory diseases continue to burden millions globally, a staggering statistic reveals that chronic obstructive pulmonary disease (COPD) ranks as one of the leading causes of death worldwide, affecting over 300 million people. This pressing health challenge has

Paul Ryan Pushes Health Care Reform and AI Amid Shutdown
Public Policy Paul Ryan Pushes Health Care Reform and AI Amid Shutdown

Overview of the U.S. Health Care Landscape The U.S. health care system stands as one of the largest and most complex sectors of the economy, touching the lives of every citizen while grappling with persistent challenges in cost, access, and quality. Accounting for nearly 18% of the nation's

Chronic Disease Management Market to Hit $17.1B by 2033
Data and Information Chronic Disease Management Market to Hit $17.1B by 2033

Overview of the Chronic Disease Management Market The global chronic disease management market stands at a critical juncture, with a staggering valuation of US$ 6.2 billion in 2025, reflecting the urgent need to address the rising tide of non-communicable illnesses worldwide. This sector

Can Direct-to-Consumer Sales Lower U.S. Drug Costs?
Care Can Direct-to-Consumer Sales Lower U.S. Drug Costs?

Understanding the U.S. Pharmaceutical Landscape and Drug Pricing Challenges The U.S. pharmaceutical industry stands at a critical juncture, grappling with public outcry over skyrocketing drug prices that often leave patients unable to afford essential medications, a crisis that demands urgent

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later